Zachary D Goodman

Summary

Affiliation: Armed Forces Institute of Pathology
Country: USA

Publications

  1. ncbi Progression of fibrosis in advanced chronic hepatitis C: evaluation by morphometric image analysis
    Zachary D Goodman
    Armed Forces Institute of Pathology, Division of Hepatic Pathology, Veterans Administration Special Reference Laboratory for Pathology, Washington, DC, USA
    Hepatology 45:886-94. 2007
  2. ncbi Drug hepatotoxicity
    Zachary D Goodman
    Division of Hepatic Pathology and the Veterans Administration Special Reference Laboratory for Pathology, Armed Forces Institute of Pathology, Room 3107, 14th Street and Alaska Avenue, NW, Washington, DC 20306, USA
    Clin Liver Dis 6:381-97. 2002
  3. ncbi Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial
    Zachary D Goodman
    Armed Forces Institute of Pathology and Veterans Administration Special Reference Laboratory for Pathology, Washington, DC, USA
    Hepatology 47:836-43. 2008
  4. ncbi Grading and staging systems for inflammation and fibrosis in chronic liver diseases
    Zachary D Goodman
    Armed Forces Institute of Pathology, Department of Hepatic and Gastrointestinal Pathology and Veterans Administration Special Reference Laboratory for Pathology, Washington, DC, USA
    J Hepatol 47:598-607. 2007
  5. ncbi Glypican-3 expression in benign liver tissue with active hepatitis C: implications for the diagnosis of hepatocellular carcinoma
    Hala M Abdul-Al
    Division of Hepatic Pathology and the Veterans Administration Special Reference Laboratory for Pathology, Armed Forces Institute of Pathology, Washington, DC 20306 6000, USA
    Hum Pathol 39:209-12. 2008
  6. ncbi Fibrosis progression in chronic hepatitis C: morphometric image analysis in the HALT-C trial
    Zachary D Goodman
    Armed Forces Institute of Pathology, Division of Hepatic Pathology and Veterans Administration Special Reference Laboratory for Pathology, Washington, DC, USA
    Hepatology 50:1738-49. 2009
  7. ncbi Calcifying nested stromal-epithelial tumors of the liver: a clinicopathologic, immunohistochemical, and molecular genetic study of 9 cases with a long-term follow-up
    Hala R Makhlouf
    Department of Hepatic and Gastrointestinal Pathology, Armed Forces Institute of Pathology, 6825 16th Street, N W, Building 54, Washington, DC 20306 6000, USA
    Am J Surg Pathol 33:976-83. 2009
  8. ncbi Fibrolamellar hepatocellular carcinoma: an immunohistochemical comparison with conventional hepatocellular carcinoma
    Hala M Abdul-Al
    Armed Forces Institute of Pathology, Washington, DC, USA
    Int J Surg Pathol 18:313-8. 2010
  9. ncbi More severe parenchymal injury in chronic hepatitis C acquired by recent injection drug use
    Matthew M Yeh
    Department of Pathology, George Washington University School of Medicine, Washington, DC, and the Department of Medicine, Veterans Affairs Medical Center, Washington, DC, USA
    J Clin Gastroenterol 39:722-7. 2005
  10. ncbi Globular hepatic amyloid: an early stage in the pathway of amyloid formation: a study of 20 new cases
    Hala R Makhlouf
    Division of Hepatic Pathology, Department of Hepatic and Gastrointestinal Pathology, and the Veterans Administration Special Reference Laboratory for Pathology, Armed Forces Institute of Pathology, Washington, DC 20306, USA
    Am J Surg Pathol 31:1615-21. 2007

Detail Information

Publications28

  1. ncbi Progression of fibrosis in advanced chronic hepatitis C: evaluation by morphometric image analysis
    Zachary D Goodman
    Armed Forces Institute of Pathology, Division of Hepatic Pathology, Veterans Administration Special Reference Laboratory for Pathology, Washington, DC, USA
    Hepatology 45:886-94. 2007
    ..CONCLUSION: In advanced chronic hepatitis C, fibrosis increases at a rapid pace that can only be detected by morphometry. This technique can be used in future therapeutic trials of agents to inhibit fibrosis progression...
  2. ncbi Drug hepatotoxicity
    Zachary D Goodman
    Division of Hepatic Pathology and the Veterans Administration Special Reference Laboratory for Pathology, Armed Forces Institute of Pathology, Room 3107, 14th Street and Alaska Avenue, NW, Washington, DC 20306, USA
    Clin Liver Dis 6:381-97. 2002
    ....
  3. ncbi Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial
    Zachary D Goodman
    Armed Forces Institute of Pathology and Veterans Administration Special Reference Laboratory for Pathology, Washington, DC, USA
    Hepatology 47:836-43. 2008
    ....
  4. ncbi Grading and staging systems for inflammation and fibrosis in chronic liver diseases
    Zachary D Goodman
    Armed Forces Institute of Pathology, Department of Hepatic and Gastrointestinal Pathology and Veterans Administration Special Reference Laboratory for Pathology, Washington, DC, USA
    J Hepatol 47:598-607. 2007
    ....
  5. ncbi Glypican-3 expression in benign liver tissue with active hepatitis C: implications for the diagnosis of hepatocellular carcinoma
    Hala M Abdul-Al
    Division of Hepatic Pathology and the Veterans Administration Special Reference Laboratory for Pathology, Armed Forces Institute of Pathology, Washington, DC 20306 6000, USA
    Hum Pathol 39:209-12. 2008
    ..Pathologists should be aware of this phenomenon and exercise caution in interpreting biopsies or other specimens of suspected hepatocellular carcinoma when active necroinflammatory disease is present...
  6. ncbi Fibrosis progression in chronic hepatitis C: morphometric image analysis in the HALT-C trial
    Zachary D Goodman
    Armed Forces Institute of Pathology, Division of Hepatic Pathology and Veterans Administration Special Reference Laboratory for Pathology, Washington, DC, USA
    Hepatology 50:1738-49. 2009
    ..CONCLUSION: Morphometry demonstrated complex, nonlinear changes in fibrosis over time in this heterogeneous cohort of patients with interferon-refractory chronic hepatitis C...
  7. ncbi Calcifying nested stromal-epithelial tumors of the liver: a clinicopathologic, immunohistochemical, and molecular genetic study of 9 cases with a long-term follow-up
    Hala R Makhlouf
    Department of Hepatic and Gastrointestinal Pathology, Armed Forces Institute of Pathology, 6825 16th Street, N W, Building 54, Washington, DC 20306 6000, USA
    Am J Surg Pathol 33:976-83. 2009
    ..On the basis of currently available information, this tumor is best considered a low-grade malignancy...
  8. ncbi Fibrolamellar hepatocellular carcinoma: an immunohistochemical comparison with conventional hepatocellular carcinoma
    Hala M Abdul-Al
    Armed Forces Institute of Pathology, Washington, DC, USA
    Int J Surg Pathol 18:313-8. 2010
    ..All tumors had CD34-positive sinusoids. This study shows that FLCs and HCCs differ in the expression of GPC3, CK7, and CK19 and that there is a lack of difference as regards survivin and CD34...
  9. ncbi More severe parenchymal injury in chronic hepatitis C acquired by recent injection drug use
    Matthew M Yeh
    Department of Pathology, George Washington University School of Medicine, Washington, DC, and the Department of Medicine, Veterans Affairs Medical Center, Washington, DC, USA
    J Clin Gastroenterol 39:722-7. 2005
    ..The availability of material from a cohort of patients who had liver biopsy for IDU-related hepatitis C in the 1970s enabled us to compare the histology with that of current patients...
  10. ncbi Globular hepatic amyloid: an early stage in the pathway of amyloid formation: a study of 20 new cases
    Hala R Makhlouf
    Division of Hepatic Pathology, Department of Hepatic and Gastrointestinal Pathology, and the Veterans Administration Special Reference Laboratory for Pathology, Armed Forces Institute of Pathology, Washington, DC 20306, USA
    Am J Surg Pathol 31:1615-21. 2007
    ....
  11. ncbi Expression of estrogen and progesterone receptors and inhibin-alpha in hepatobiliary cystadenoma: an immunohistochemical study
    Hala M Abdul-Al
    Division of Hepatic Pathology, Department of Hepatic and Gastrointestinal Pathology, Armed Forces Institute of Pathology, Washington, DC 20306 6000, USA
    Virchows Arch 450:691-7. 2007
    ..The expression of ER, PR, and inhibin-alpha in the ovarian-like stroma supports the likely hormonal dependence of this tumor and probably explains its almost exclusive occurrence in women...
  12. ncbi Diagnosis of focal nodular hyperplasia of the liver by needle biopsy
    Hala R Makhlouf
    Division of Hepatic Pathology, Department of Hepatic and Gastrointestinal Pathology, Armed Forces Institute of Pathology, Washington, DC 20306 6000, USA
    Hum Pathol 36:1210-6. 2005
    ....
  13. ncbi Neoplasms of the liver
    Zachary D Goodman
    Department of Hepatic and Gastrointestinal Pathology, Armed Forces Institute of Pathology, Washington, DC, USA
    Mod Pathol 20:S49-60. 2007
    ..Cholangiocarcinoma resembles adenocarcinomas arising in other tissues, so a definitive diagnosis relies on the exclusion of an extrahepatic primary and distinction from benign biliary lesions...
  14. ncbi Primary gallbladder sarcoma: a clinicopathologic study of 15 cases, heterogeneous sarcomas with poor outcome, except pediatric botryoid rhabdomyosarcoma
    Wael I Al-Daraji
    Department of Soft Tissue and Orthopaedic Pathology, Armed Forces Institute of Pathology, Washington, DC 20306 6000, USA
    Am J Surg Pathol 33:826-34. 2009
    ..Primary gallbladder sarcoma (PGBS) is rare, with only 39 documented cases, with the predominant type being leiomyosarcoma...
  15. ncbi Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort
    Anna S F Lok
    Division of Gastroenterology, University of Michigan Medical Center, 3912 Taubman Center, Ann Arbor, MI 48210, USA
    Hepatology 42:282-92. 2005
    ..In conclusion, a model based on standard laboratory test results can be used to predict histological cirrhosis with a high degree of accuracy in 50% of patients with CHC...
  16. ncbi Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C
    Robert J Fontana
    Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA
    Hepatology 47:789-98. 2008
    ..The stronger correlation of the serum markers with Ishak scores suggests that serum fibrosis markers reflect the pattern of fibrosis more closely than the quantity of hepatic collagen...
  17. ncbi Histopathological changes after microwave coagulation therapy for patients with hepatocellular carcinoma: review of 15 explanted livers
    Noriyo Yamashiki
    Division of Hepatology, Department of Medicine, University of Miami School of Medicine, Miami, Florida, USA
    Am J Gastroenterol 98:2052-9. 2003
    ..Pathologists need to be aware that after this form of therapy, portions of the tumor maintain their native morphological features as if the area is fixed, but their cellular activity is destroyed...
  18. ncbi Best practices in diagnostic immunohistochemistry: hepatocellular carcinoma versus metastatic neoplasms
    Sanjay Kakar
    Department of Pathology, Veteran Affairs and University of California Medical Center, San Francisco, CA 94121, USA
    Arch Pathol Lab Med 131:1648-54. 2007
    ..Because limited tissue is available with fine-needle and core biopsies, appropriate selection of antibodies is imperative...
  19. ncbi Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment
    Mitchell L Shiffman
    Hepatology Section, Virginia Commonwealth University, Richmond, 23298, USA
    Gastroenterology 126:1015-23; discussion 947. 2004
    ..This study evaluated the effectiveness of this treatment in patients who were nonresponders to previous interferon-based therapy...
  20. ncbi Diabetic hepatosclerosis: diabetic microangiopathy of the liver
    Stephen A Harrison
    Liver Center, Department of Medicine, Saint Louis University School of Medicine, St Louis, MO 63110, USA
    Arch Pathol Lab Med 130:27-32. 2006
    ..Further studies are needed to precisely characterize diabetic hepatosclerosis and to understand mechanisms of pathogenesis and the clinical significance...
  21. ncbi Idiopathic adulthood ductopenia associated with hepatitis C virus
    Ali T Dural
    Department of Medicine, Veterans Affairs Medical Center, Baylor College of Medicine, Houston, Texas 77030, USA
    Dig Dis Sci 47:1625-6. 2002
  22. ncbi Liver biopsy in cirrhotic patients
    Kenneth E Sherman
    University of Cincinnati College of Medicine, Division of Digestive Diseases, Cincinnati, Ohio 45267 0595, USA
    Am J Gastroenterol 102:789-93. 2007
    ..No specific safety issues attributable to a particular biopsy method were identified...
  23. ncbi Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis
    Paul J Pockros
    Division of Gastroenterology Hepatology, Scripps Clinic, La Jolla, CA 92037, USA
    Hepatology 45:569-78. 2007
    ..Subgroups of patients with elevated ITAC levels and perhaps less advanced disease may be considered for future studies with IFN-gamma1b...
  24. ncbi Pathologic assessment of non-alcoholic fatty liver disease
    Silvia Bondini
    Center for Liver Diseases at Inova Fairfax Hospital, 3300 Gallows Road, Falls Church, VA 22042, USA
    Clin Liver Dis 11:17-23, vii. 2007
    ..This article reviews some of the studies dealing with the histopathology of NAFLD, with attempts to develop a standardized pathologic scoring system for NASH...
  25. ncbi Hepatic iron concentration does not influence response to therapy with interferon plus ribavirin in chronic HCV infection
    Stephen Pianko
    Scripps Clinic and Research Foundation, La Jolla, CA 92037, USA
    J Interferon Cytokine Res 22:483-9. 2002
    ..IFN monotherapy nonresponder patients tended to have a higher HIC. With IFN plus ribavirin, the sustained virologic response rate was not affected by the HIC...
  26. ncbi Hepatic adenocarcinoma expressing inhibin in a young patient on oral contraceptives
    Eleni Vrettou
    Department of Pathology, Aristotle University Medical School, 540 06 Thessaloniki, Greece
    Virchows Arch 446:560-5. 2005
    ..In conclusion, this unique case may represent a rare variant of cholangiocarcinoma expressing inhibin...
  27. ncbi Giant cell tumor of the extrahepatic biliary tree: a clinicopathologic study of 4 cases and comparison with anaplastic spindle and giant cell carcinoma with osteoclast-like giant cells
    Jorge Albores-Saavedra
    Department of Pathology, Louisiana State University Health Sciences Center, Shreveport, LA, USA
    Am J Surg Pathol 30:495-500. 2006
    ....
  28. ncbi Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin
    John G McHutchison
    Division of Gastroenterology Hepatology, Scripps Clinic and Research Foundation, 10666 N Torrey Pines Road N203, La Jolla, CA 92037, USA
    Hepatology 35:688-93. 2002
    ..In conclusion, measurement of hepatic HCV RNA before or after therapy reflects changes observed in serum HCV RNA, and correlates inversely with hepatic inflammation and fibrosis, but otherwise has minimal clinical use...